Watchlist
Loading...
US Stock MarketDetailed Quotes

NBSE NeuBase Therapeutics

Watchlist
0.8100 +0.0399+5.18% Close 12/08 16:00 ET
0.7900-0.0200-2.47% Post 17:22 ET
0.9314High0.7470Low203.25KVolume
Full Hours
  • 5D
  • 1D
  • 1W
  • 1M
  • 1Q
  • 1Y

About NeuBase Therapeutics Company

NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on August 4, 2009 and is headquartered in Pittsburgh, PA.

Revenue Breakdown

Business Currency:USD
2005/12/31
Stock NameRevenueRatio
Insurance Products6.44B90.03%
Asset Management/Belsen Getty668.6M9.34%
Other45.07M0.63%

Comments

Read more
Paper Trade Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Claim up to $1 million virtual fund, join moomoo paper trading today! Claim Now >